References
- Chen T. J., Chou Y. C., Chen C. H., Kuo T. T., Hong H. S. Genital porokeratosis: A series of 10 patients and review of the literature. Br J Dermatol 2006; 155: 325–9
- Huang S. L., Liu Y. H., Chen W. Genitogluteal porokeratosis. J Eur Acad Dermatol Venereol 2006; 20: 899–900
- Schamroth J. M., Zlotogorski A., Gilead L. Porokeratosis of Mibelli. Overview and review of the literature. Acta Derm Venereol 1997; 77: 207–13
- Agrawal S. K., Gandhi V., Madan V., Bhattacharya S. N. Topical tretinoin in Indian male with zosteriform porokeratosis. Int J Dermatol 2003; 42: 919–20
- Bohm M., Luger T. A., Bonsmann G. Disseminated superficial actinic porokeratosis: Treatment with topical tacalcitol. J Am Acad Dermatol 1999; 40: 479–80
- Cavicchini S., Tourlaki A. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate‐photodynamic therapy. J Dermatolog Treat 2006; 17: 190–1
- Arranz‐Salas I., Sanz‐Trelles A., Ojeda D. B. p53 alterations in porokeratosis. J Cutan Pathol 2003; 30: 455–8
- Kim K. H., Park E. J., Seo Y. J., Cho H. S., Kim C. W., Kim K. J., et al. Immunohistochemical study of cyclooxygenase‐2 and p53 expression in skin tumors. J Dermatol 2006; 33: 319–25
- Nelson C., Rigel D., Smith S., Swanson N., Wolf J. Phase IV, open‐label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol 2004; 3: 401–7